Feng Jin

Feng Jin

Auto-generated profile, based on publicly available information

Feng Jin

Hebei University of Chinese Medicine, Shijiazhuang 050200, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Archives of Medical Research
Verified
Journal Article
Open access
WLWei Li
Wei Li
SWShuo Wang
Shuo Wang
HWHao Wang
Hao Wang
JWJiepeng Wang
Jiepeng Wang
FJFeng Jin
Feng Jin
CFChaoyi Fang
Chaoyi Fang
We investigated the effects of astragaloside IV (AS-IV) on memory function in aging rats mimicked by D-galactose administration and explored the potential molecular mechanisms. Twenty-seven male rats were randomly divided into control group (N = 9), model group (N = 9), and AS-IV treated group (N = 9). Aging model was stimulated by D-galactose (400 mg/kg/d, i.p., dissolved in saline) for 8 weeks in rats. The general status of the rats was observed weekly. Learning and memory function was determined using the eight-arm radical maze and step-down test. Pathological changes in the hippocampal CA1 region were determined by hematoxylin and eosin staining. Organ indexes, superoxide dismutase (SOD) activity and malonaldehyde (MDA) content in the serum were measured. Expression of advanced glycation end products (AGEs), receptor for AGEs (RAGE), nuclear factor-κB (NF-κB), interleukin (IL)-6, IL-1β and tumor necrosis factor-α (TNF-α) were detected by enzyme-linked immunosorbent assay, real-time polymerase chain reaction or western blotting. AS-IV improved the general status of the aging rats induced by D-galactose, prevented the impairment of memory function, organ indexes, and the pathological damage of the hippocampus. From the prospective of oxidative stress, AS-IV increased sera SOD activity and decreased MDA content. Additionally, AS-IV also reduced the inflammatory response by reducing hippocampal IL-1β, TNF-α, and IL-6 expression. Importantly, AS-IV prevented D-galactose-induced expression of AGEs, RAGE and NF-κB in the hippocampus. AS-IV could prevent D-galactose-induced aging and memory impairment in rats, likely via regulation of inflammatory response, which was modulated by AGEs/RAGE/NF-κB axis.

1 March 2021 in International Journal of Immunogenetics
Verified
Journal Article
Closed access
PDF file
FJFeng Jin
Feng Jin
LLLeming Liao
Leming Liao
YZYongjun Zhu
Yongjun Zhu

1 October 2017 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Open access
PDF file
RWR. Wang
R. Wang
FJF. Jin
F. Jin
JYJie Yang
Jie Yang
QHQ. He
Q. He
Hang JiangHang Jiang
Hang Jiang
Purpose/Objective(s) To investigate the expression of Per1, Per2 and Per3 in head and neck squamous cell carcinoma(HNSCC); detect the relationship between Per1, Per2,Per3 gene expression level and clinical stages of HNSCC; explore the association of Per1, Per2,Per3 protein expression with clinical features, clinical stages and survival of HNSCC. Materials/Methods The 7 normal tissue samples and 20 HNSCC tissue were collected. QPCR method was used to detect the expression of Per1, Per2 ,Per3 genes in HNSCC tissue and normal tissues. Based on patient clinical stages, (I-II) was identified as early group,(III-IV) was identified as late group. Explore the gene expression of Per1, Per2,Per3 in early and late stages. In the same time, 60 HNSCC tissue and 20 normal tissue were collected. Immunohistochemistry was used, the product of multiplying by staining grading and staining cell percentage was used to determine Per1, Per2, Per3 protein expression. Results The expression of Per1, Per2,Per3 gene expression in HNSCC tissue was reduced compared with normal tissue (P<0.01). The patient of late stage, reduction levels of Per2 and Per3 genes was higher than early stage. According to immunohistochemistry, protein positive rate of Per1, Per2,Per3 genes in normal tissue was higher that of Per1, Per2,Per3 genes in HNSCC tissue (P<0.05). For the patient of HNSCC, OS in Per1 and Per3 negative groups in 1 year,2 years,3 years were 80.6%, 51.6% and 29%, respectively; positive groups in 1 year, 2 years and 3 years were 98.6%, 86.2% and 72.4%(P0.05). In Per1 and Per3 protein positive groups, PFS in 1 year, 2 years and 3 years were 96.6%, 69% and 55.2%, respectively; in negative groups, PFS in 1 year, 2 years and 3 years were 71%, 32.3% and 16.1%(P<0.05).PFS in Per2 positive group in 1 year, 2 years and 3 years were 96.3%, 77.8% and 59.2%, respectively; negative group in 1 year, 2 years and 3 years were 72.7%, 33.3% and 24.2% (P<0.05); RFS in Per1 and Per3 negative groups in 1 year, 2 years and 3 years were 77.4%, 45.2% and 35.5%, respectively; positive group in 1 year, 2 years and 3 years were 96.6%, 82.8% and 67.7% (P<0.05). RFS in Per2 protein negative group in 1 year, 2 years and 3 years were 81.8%, 48.4.% and 36.3%, respectively; positive group in 1 year, 2 years and 3 years were 96.3%, 81.5% and 66.7% (P<0.05). Conclusion Per1, Per2 and Per3 genes may play a critical role in the occurrence and development of HNSCC,compared with negative Per1 and Per3 protein expression, patients with positive Per1 and Per3 protein expression may have longer OS and show the trend of extended PFS and RFS.